Evonile Pharma Ltd. Rights Issue 2026
Evonile Pharma Ltd. Rights Entitlement & Capital Calculator
Calculate your eligible rights share allocation and total application cost based on the official 5:12 ratio at ₹860.00 per share.
Evonile Pharma Ltd. Stock Quote & Price Trend
| Date | Closing Price (₹) | Comparison vs Issue Price (₹860.00) |
|---|---|---|
| 18 Nov 2026 | ₹1416.40 | +₹556.40 Premium |
| 17 Nov 2026 | ₹1467.80 | +₹607.80 Premium |
| 16 Nov 2026 | ₹1499.20 | +₹639.20 Premium |
| 13 Nov 2026 | ₹1520.40 | +₹660.40 Premium |
| 12 Nov 2026 | ₹1589.60 | +₹729.60 Premium |
| 11 Nov 2026 | ₹1568.10 | +₹708.10 Premium |
| 09 Nov 2026 | ₹1569.55 | +₹709.55 Premium |
| 06 Nov 2026 | ₹1479.68 | +₹619.68 Premium |
| 05 Nov 2026 | ₹1444.42 | +₹584.42 Premium |
| 04 Nov 2026 | ₹1442.57 | +₹582.57 Premium |
| 03 Nov 2026 | ₹1449.39 | +₹589.39 Premium |
| 02 Nov 2026 | ₹1445.43 | +₹585.43 Premium |
| 30 Oct 2026 | ₹1692.40 | +₹832.40 Premium |
| 29 Oct 2026 | ₹1812.80 | +₹952.80 Premium |
| 28 Oct 2026 | ₹1821.40 | +₹961.40 Premium |
Issue Overview & Specifications
| Company Name | Evonile Pharma Ltd. |
|---|---|
| Rights Entitlement (Ratio) |
5:12
(5 share for every 12 held)
|
| Issue Price | ₹860 per equity share |
| Face Value | N/A |
| Total Issue Size | ₹884.75 Crores |
| Number of Shares Offered | TBA |
| Listing Exchanges | BSE, NSE |
| Equity Shares ISIN | INE234A01025 |
| Registrar to the Issue | [email protected] |
Evonile Pharma Ltd. Rights Issue Timetable
Cut-off date determining eligible shareholders entitled to receive Rights Entitlements (RE).
Bidding opens. Eligible investors can apply online via Net Banking ASBA.
Last trading day to sell or transfer your Rights Entitlements (RE) on the stock exchange.
Final deadline to submit your ASBA rights issue application with blocked funds.
Finalization of allotment by the registrar and company.
Allotted rights shares are credited to demat accounts and commence trading on BSE/NSE.
How to Apply for Evonile Pharma Ltd. Rights Issue
Check Rights Entitlement (RE) in Demat
Once the record date passes, Rights Entitlements (RE) will be credited directly to your demat account under temporary ISIN NOVARTIND-RE.
Decide: Apply, Renounce (Sell), or Apply for Additional Shares
You can apply for your exact entitlement, apply for additional shares over and above your entitlement, or sell your RE shares in the stock market before the renunciation deadline.
Apply via Net Banking ASBA
Log in to your bank's net banking portal (HDFC, ICICI, SBI, Axis, Kotak, etc.). Go to IPO / Rights Issue section, select Evonile Pharma Ltd. Rights Issue, enter your Demat account (BOID/DPID) details, and submit.